BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6984235)

  • 21. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors].
    Nikulin NK; Starostina ZD; Komarova VD
    Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immunological dysfunction in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1982 Feb; 23(1):12-8. PubMed ID: 6214005
    [No Abstract]   [Full Text] [Related]  

  • 23. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 24. [Function of the Fc receptors].
    Alarcón-Segovia D
    Gac Med Mex; 1980 Apr; 116(4):174-6. PubMed ID: 6967031
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study of rosette-forming lymphocytes in peripheral blood of patients with systemic lupus erythematosus].
    Komarov FI; Savel'ev AI; Frumina EI; Pukhal'skiĭ AL; Gutorova NM
    Ter Arkh; 1974; 46(11):78-82. PubMed ID: 4548225
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathogenesis of immune dysregulation in systemic lupus erythematosus. A troika.
    Alarcón-Segovia D
    J Rheumatol; 1984 Oct; 11(5):588-90. PubMed ID: 6239922
    [No Abstract]   [Full Text] [Related]  

  • 27. [Role of antilymphocytic antibodies in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(5):699-705. PubMed ID: 1087422
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytotoxicity of human lymphocytes induced by antibody: response in patients with systemic lupus erythematosus and effect of immunosuppressive treatment].
    Manni JA; de Bracco MM; Patrucco A
    Medicina (B Aires); 1974; 34(3):185-93. PubMed ID: 4547009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cellular and humoral factors of immunogenesis of sytemic lupus erythematosus and systemic scleroderma].
    Demin AA; Galenok VA; Kolesnuk VV; Finchenko AF
    Klin Med (Mosk); 1973 Nov; 51(11):100-4. PubMed ID: 4787290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Various indices of cellular and humoral immunity in patients with chronic glomerulonephritis].
    Belovezhdov N; Altynkova I
    Ter Arkh; 1981; 53(12):78-82. PubMed ID: 6977884
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cellular immunity and antibody production system in systemic lupus erythematosus].
    Nagura Y
    Nihon Jinzo Gakkai Shi; 1975 Feb; 17(2):103-20. PubMed ID: 1241991
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic and prognostic significance of indicators of humoral and cellular immunity in patients with lupus erythematosus].
    Konstantinova NA; Koval'chuk LV; Cheredeev AN; Mattess Kh; Trofimova LIa
    Sov Med; 1983; (5):30-4. PubMed ID: 6612458
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antibody dependent cell-bound cytotoxicity in systemic lupus erythematosus].
    Láng I; Fekete B; Török K; Pálóczi K; Sonkoly I; Szegedi G; Gergely P
    Orv Hetil; 1978 Jul; 119(31):1885-7. PubMed ID: 307723
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of T-cells and B-cells in SLE and RA].
    Nakai H; Nakamura T; Tanimoto K
    Nihon Rinsho; 1978 Dec; 36(12):3945-50. PubMed ID: 311861
    [No Abstract]   [Full Text] [Related]  

  • 36. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
    Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
    Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-immunological evaluation of the efficacy of treatment of patients with furunculosis].
    Savitskaia LN
    Vestn Dermatol Venerol; 1983 Mar; (3):4-9. PubMed ID: 6602435
    [No Abstract]   [Full Text] [Related]  

  • 38. [Laboratory studies of several immunologic and biochemical indicators in patients with congenital defects of the 1st and 2d branchial arches].
    Kotov GA; Iarchuk NI; Khavinson VKh; Morozov VG; Kozhemiakin AL
    Lab Delo; 1983; (11):11-3. PubMed ID: 6197563
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of the functional state of the human T-immunity system].
    Antonenko VT; Skuratovskiĭ MF
    Vrach Delo; 1980 Apr; (4):77-80. PubMed ID: 6966865
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanism of cellular immunity in autoimmune diseases].
    Sakane T; Suzuki N
    Nihon Rinsho; 1988 Apr; 46(4):755-63. PubMed ID: 3261356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.